Bladder Neoplasm: Clinical Trials

3 trials for Bladder Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 recruiting. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 2, Recruiting 1

Follow Bladder Neoplasm: new trials by email Literature Review of Bladder Neoplasm trials Research Report on Bladder Neoplasm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
multiparametric magnetic resonance imaging (mpMRI) of the bladder, Transurethral resection of bladder tumour (TURBt), Circulating tumour DNA levels assessment - Bladder (Urothelial, Transitional Cell) Cancer, Bladder Cancer Requiring Cystectomy
Phase 3RecruitingUniversity of Rome Tor Vergata922025-08-152025-07-24
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.
Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm
Phase 3TerminatedMedical Enterprises Ltd.52019-04-042020-04-15
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
EN3348, Mitomycin C - Bladder Neoplasm, Neoplasm Recurrence, Local
Phase 3TerminatedBioniche Life Sciences Inc.842010-11-012017-08-24

Narrower conditions

Urinary Bladder Neoplasms (3)  ·  Neoplasms (2)  ·  Carcinoma in Situ (1)  ·  Carcinoma, Transitional Cell (1)  ·  Disease (1)  ·  Mycobacterium Infections (1)  ·  Neoplasm Recurrence, Local (1)  ·  Neoplasms by Site (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Neoplasms by Site (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urinary Bladder Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Urologic Diseases (2)  ·  Urologic Neoplasms (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Carcinoma (1)

Interventions

Mitomycin (2)  ·  Multiparametric Magnetic Resonance Imaging (1)  ·  Transurethral Resection of Bladder (1)

Sponsors

Bioniche Life Sciences Inc. (1)  ·  Medical Enterprises Ltd. (1)  ·  University of Rome Tor Vergata (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Michael A O'Donnell, MD (1)  ·  Simone Albisinni, MD, Phd, FEBU (1)